Clinical trial

Pancreatic Clamp in NAFLD

NCT05724134

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-08-29

PhasePHASE1

Study timeline

Study start (actual)2023-08-29Date precision: day

Registry last updated2026-01-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Insulin Resistanceunresolved

Prediabetic Stateunresolved

Hyperinsulinemiaunresolved

Non-Alcoholic Fatty Liver Diseaseverified · MONDO: metabolic dysfunction-associated steatotic liver disease

Obesityverified · MONDO: obesity disorder

Interventions

Insulin humanDRUG

Octreotide AcetateDRUG · verified · RxNorm: octreotide acetate

GlucagonDRUG · verified · RxNorm: glucagon

Growth Hormone, HumanDRUG

[6,6-2H2] D-glucoseOTHER

20% D-glucose (aq)DRUG

BOOST PlusDIETARY_SUPPLEMENT

CORE BarDIETARY_SUPPLEMENT

Harvard Apparatus PHD ULTRA CP syringe pumpDEVICE

Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate AnalyzerDEVICE

Sponsors & collaborators

Columbia Universitylead sponsor

Albert Einstein College of Medicinecollaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05724134 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.